Susquehanna International Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,273
| Closed | -$422K | – | 6697 |
|
|
2025
Q1 | $422K | Buy |
13,273
+4,966
| +60% | +$158K | ﹤0.01% | 4569 |
|
|
2024
Q4 | $323K | Sell |
8,307
-13,781
| -62% | -$535K | ﹤0.01% | 4668 |
|
|
2024
Q3 | $994K | Sell |
22,088
-7,995
| -27% | -$360K | ﹤0.01% | 2686 |
|
|
2024
Q2 | $1.26M | Buy |
30,083
+24,793
| +469% | +$1.04M | ﹤0.01% | 2264 |
|
|
2024
Q1 | $241K | Sell |
5,290
-2,198
| -29% | -$100K | ﹤0.01% | 4468 |
|
|
2023
Q4 | $346K | Buy |
+7,488
| New | +$346K | ﹤0.01% | 4358 |
|
|
2023
Q2 | – | Sell |
-15,454
| Closed | -$762K | – | 5982 |
|
|
2023
Q1 | $762K | Buy |
+15,454
| New | +$762K | ﹤0.01% | 3260 |
|
|
2022
Q4 | – | Sell |
-6,480
| Closed | -$325K | – | 6208 |
|
|
2022
Q3 | $325K | Buy |
+6,480
| New | +$325K | ﹤0.01% | 4132 |
|
|
2022
Q2 | – | Sell |
-11,600
| Closed | -$697K | – | 6142 |
|
|
2022
Q1 | $697K | Buy |
+11,600
| New | +$697K | ﹤0.01% | 3288 |
|
|
2021
Q4 | – | Sell |
-18,709
| Closed | -$1.67M | – | 6054 |
|
|
2021
Q3 | $1.67M | Buy |
18,709
+10,880
| +139% | +$969K | ﹤0.01% | 2144 |
|
|
2021
Q2 | $779K | Sell |
7,829
-18,417
| -70% | -$1.83M | ﹤0.01% | 3329 |
|
|
2021
Q1 | $2.36M | Buy |
26,246
+18,693
| +247% | +$1.68M | ﹤0.01% | 1922 |
|
|
2020
Q4 | $716K | Sell |
7,553
-3,265
| -30% | -$310K | ﹤0.01% | 2991 |
|
|
2020
Q3 | $778K | Buy |
+10,818
| New | +$778K | ﹤0.01% | 2534 |
|
|
2020
Q1 | – | Sell |
-8,965
| Closed | -$560K | – | 4748 |
|
|
2019
Q4 | $560K | Buy |
8,965
+3,151
| +54% | +$197K | ﹤0.01% | 2543 |
|
|
2019
Q3 | $291K | Buy |
+5,814
| New | +$291K | ﹤0.01% | 3442 |
|